CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Site Search
Showing 1 - 5 of 5 results
Press Release
|
Feb. 22, 2010
|
4 min read
Proposed legislation has the potential to revitalize the global marketplace for novel antibiotics, bringing urgently needed medicines for drug-resistant infections to patients.
Press Release
|
June 16, 2021
|
2 min read
Today, the Cystic Fibrosis Foundation announced it has awarded up to $3.3 million to Polyphor AG to develop an inhaled version of murepavadin, an antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in people with cystic fibrosis. About 17% of individuals with CF who had Pseudomonas infections last year had multi-drug resistant strains.
Press Release
|
Nov. 24, 2020
|
3 min read
Treatment plans help people with cystic fibrosis maintain their health so they can live longer, more fulfilling lives. Although every treatment plan is unique, comprehensive CF treatment plans usually include quarterly visits to a CF care center and the following components: airway clearance techniques; oral, inhaled and nebulized medications; nutrition therapies; and a fitness plan.
Airway clearance techniques (ACTs) loosen thick, sticky mucus so it can be cleared from your lungs by coughing or huffing. Clearing the airways may help decrease lung infections and improve lung function.